Skip to main content
Top
Published in: Pathology & Oncology Research 1/2016

01-01-2016 | Original Article

Expression of LC3, LAMP2, KEAP1 and NRF2 in Salivary Adenoid Cystic Carcinoma

Authors: Cong-Fa Huang, Wei-Wei Deng, Lu Zhang, Wen-Feng Zhang, Zhi-Jun Sun

Published in: Pathology & Oncology Research | Issue 1/2016

Login to get access

Abstract

Salivary Adenoid Cystic Carcinoma (SACC) is a tumor characterized by inevitable local progression and terminal hematogenous metastasis. This study aimed to investigate the expression of LC3, LAMP2, KEAP1 and NRF2 in SACC. Human salivary gland tissue microarray which contains 74 SACC, 12 pleomorphic adenoma and 18 normal salivary gland specimens. High expression of LC3, LAMP2, KEAP1 and NRF2 were found in SACC patients, and LC3, LAMP2, KEAP1 and NRF2 expression were significantly higher in SACC than as compared with pleomorphic adenoma and (or) normal salivary gland. The expression of NRF2 was correlated with pathological type of human SACC (P < 0.05). Moreover, the high-expression of KEAP1 had significant correlations with LC3 (P < 0.001, R = 0.3195), and LAMP2 (P < 0.001, R = 0.3346) and NRF2 (P < 0.05, R = 0.2246) by using the Pearson correlation coefficient test. Our findings demonstrated that up-regulation of LC3, LAMP2, KEAP1 and NRF2 were associated with carcinogenesis and progression of SACC patients, suggesting that they may be useful molecular targets in salivary adenoid cystic carcinoma.
Literature
1.
go back to reference Wang YF, Zhang W, He KF, Liu B, Zhang L, et al. (2014) Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma. Apoptosis 19:748–758PubMedCentralCrossRefPubMed Wang YF, Zhang W, He KF, Liu B, Zhang L, et al. (2014) Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma. Apoptosis 19:748–758PubMedCentralCrossRefPubMed
2.
go back to reference Tang QL, Fan S, Li HG, Chen WL, Shen XM, et al. (2011) Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis. Oral Oncol 47:365–370CrossRefPubMed Tang QL, Fan S, Li HG, Chen WL, Shen XM, et al. (2011) Expression of Cyr61 in primary salivary adenoid cystic carcinoma and its relation to Ki-67 and prognosis. Oral Oncol 47:365–370CrossRefPubMed
3.
go back to reference Munafo DB, Colombo MI (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114:3619–3629PubMed Munafo DB, Colombo MI (2001) A novel assay to study autophagy: regulation of autophagosome vacuole size by amino acid deprivation. J Cell Sci 114:3619–3629PubMed
4.
go back to reference Meijer AJ, Dubbelhuis PF (2004) Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 313:397–403CrossRefPubMed Meijer AJ, Dubbelhuis PF (2004) Amino acid signalling and the integration of metabolism. Biochem Biophys Res Commun 313:397–403CrossRefPubMed
5.
go back to reference Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151–175PubMedCentralCrossRefPubMed Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, et al. (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4:151–175PubMedCentralCrossRefPubMed
7.
go back to reference Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, Rafn B, Bottzauw T, et al. (2008) Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res 68:6623–6633CrossRefPubMed Fehrenbacher N, Bastholm L, Kirkegaard-Sorensen T, Rafn B, Bottzauw T, et al. (2008) Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2. Cancer Res 68:6623–6633CrossRefPubMed
8.
go back to reference Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, et al. (2010) Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41:503–512CrossRefPubMed Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, et al. (2010) Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 41:503–512CrossRefPubMed
9.
go back to reference Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, et al. (2013) High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 44:2558–2562CrossRefPubMed Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, et al. (2013) High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 44:2558–2562CrossRefPubMed
10.
11.
go back to reference Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40CrossRefPubMed Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1–40CrossRefPubMed
12.
go back to reference Takaya K, Suzuki T, Motohashi H, Onodera K, Satomi S, et al. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53:817–827PubMedCentralCrossRefPubMed Takaya K, Suzuki T, Motohashi H, Onodera K, Satomi S, et al. (2012) Validation of the multiple sensor mechanism of the Keap1-Nrf2 system. Free Radic Biol Med 53:817–827PubMedCentralCrossRefPubMed
13.
go back to reference Leinonen HM, Kansanen E, Polonen P, Heinaniemi M, Levonen AL (2014) Role of the keap1-nrf2 pathway in cancer. Adv Cancer Res 122:281–320CrossRefPubMed Leinonen HM, Kansanen E, Polonen P, Heinaniemi M, Levonen AL (2014) Role of the keap1-nrf2 pathway in cancer. Adv Cancer Res 122:281–320CrossRefPubMed
14.
go back to reference Huang CF, Zhang L, Ma SR, Zhao ZL, Wang WM, et al. (2013) Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma. PLoS One 8: e83479 Huang CF, Zhang L, Ma SR, Zhao ZL, Wang WM, et al. (2013) Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma. PLoS One 8: e83479
15.
go back to reference Liu C, Xu P, Chen D, Fan X, Xu Y, et al. (2013) Roles of autophagy-related genes beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomed Rep 1:855–860PubMedCentralPubMed Liu C, Xu P, Chen D, Fan X, Xu Y, et al. (2013) Roles of autophagy-related genes beclin-1 and LC3 in the development and progression of prostate cancer and benign prostatic hyperplasia. Biomed Rep 1:855–860PubMedCentralPubMed
16.
go back to reference Jiang L, Huang S, Li W, Zhang D, Zhang S, et al. (2012) Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma. Pathol Res Pract 208:635–641CrossRefPubMed Jiang L, Huang S, Li W, Zhang D, Zhang S, et al. (2012) Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma. Pathol Res Pract 208:635–641CrossRefPubMed
17.
go back to reference Mello AS, Goldim MP, Mezzalira J, Garcia CS, Daitx VV, et al. (2014) LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases. Mol Cell Biochem 385:1–6CrossRefPubMed Mello AS, Goldim MP, Mezzalira J, Garcia CS, Daitx VV, et al. (2014) LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases. Mol Cell Biochem 385:1–6CrossRefPubMed
18.
go back to reference Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL (2013) The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45–49PubMedCentralCrossRefPubMed Kansanen E, Kuosmanen SM, Leinonen H, Levonen AL (2013) The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol 1:45–49PubMedCentralCrossRefPubMed
19.
go back to reference Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34:340–346CrossRefPubMed Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34:340–346CrossRefPubMed
20.
go back to reference Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, et al. (2011) Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer 10:37PubMedCentralCrossRefPubMed Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, et al. (2011) Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Cancer 10:37PubMedCentralCrossRefPubMed
21.
go back to reference Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, et al. (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci 118:3091–3102CrossRefPubMed Gonzalez-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, et al. (2005) The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci 118:3091–3102CrossRefPubMed
22.
go back to reference Tanida I, Tanida-Miyake E, Ueno T, Kominami E (2001) The human homolog of Saccharomyces cerevisiae Apg7p is a protein-activating enzyme for multiple substrates including human Apg12p, GATE-16, GABARAP, and MAP-LC3. J Biol Chem 276:1701–1706CrossRefPubMed Tanida I, Tanida-Miyake E, Ueno T, Kominami E (2001) The human homolog of Saccharomyces cerevisiae Apg7p is a protein-activating enzyme for multiple substrates including human Apg12p, GATE-16, GABARAP, and MAP-LC3. J Biol Chem 276:1701–1706CrossRefPubMed
23.
go back to reference Gonzalez Y, Aryal B, Chehab L, Rao VA (2014) Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 5:1526–1537PubMedCentralCrossRefPubMed Gonzalez Y, Aryal B, Chehab L, Rao VA (2014) Atg7- and Keap1-dependent autophagy protects breast cancer cell lines against mitoquinone-induced oxidative stress. Oncotarget 5:1526–1537PubMedCentralCrossRefPubMed
24.
go back to reference Huber S, Valente S, Chaimbault P, Schohn H (2014) Evaluation of 2-pioglitazone, an analogue of pioglitazone, on colon cancer cell survival: evidence of drug treatment association with autophagy and activation of the Nrf2/Keap1 pathway. Int J Oncol 45:426–438PubMed Huber S, Valente S, Chaimbault P, Schohn H (2014) Evaluation of 2-pioglitazone, an analogue of pioglitazone, on colon cancer cell survival: evidence of drug treatment association with autophagy and activation of the Nrf2/Keap1 pathway. Int J Oncol 45:426–438PubMed
Metadata
Title
Expression of LC3, LAMP2, KEAP1 and NRF2 in Salivary Adenoid Cystic Carcinoma
Authors
Cong-Fa Huang
Wei-Wei Deng
Lu Zhang
Wen-Feng Zhang
Zhi-Jun Sun
Publication date
01-01-2016
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 1/2016
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-015-9981-0

Other articles of this Issue 1/2016

Pathology & Oncology Research 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine